TriSalus Life Sciences, Inc.

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+143K	72.2%	$4.72	+$673K
Sells	5	-54.8K	27.8%	$4.36	-$239K
Net	-1	+87.7K	44.4%		+$433K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
MedTech Acquisition Sponsor LLC	10%+ Owner	$65.5M			Jun 26, 2023
Frankenius Equity AB	10%+ Owner	$24.7M	+$250K	+1.02%	Feb 10, 2025
Mats Wahlstrom	Director	$10.6M			Jun 12, 2025
David J. Matlin	Director	$5.63M			Jun 12, 2025
Sean Murphy	Director	$3.82M	+$157K	+4.29%	Jun 12, 2025
Mary T. Szela	CEO AND PRESIDENT, Director	$3.52M	+$102K	+2.99%	Feb 18, 2025
George Kelly Martin	Director	$1.36M			Aug 28, 2024
David Patience	Chief Financial Officer	$1.26M			Nov 24, 2025
Arjun JJ Desai	Director	$912K	-$111K	-10.8%	Jun 12, 2025
Bryan F. Cox	Chief of Research	$790K	-$24.7K	-3.03%	Nov 24, 2025
Jennifer Stevens	Chief Regulatory Officer	$605K	-$45.1K	-6.94%	Nov 24, 2025
Richard Marshak	Chief Commercial Officer	$540K	-$34.2K	-5.95%	Nov 24, 2025
James Alecxih	President, Device Technology	$521K			Aug 10, 2023
Jodi Devlin	Chief of Clinical Operations	$477K	-$24.7K	-4.92%	Nov 24, 2025
James Emmett Young	Chief Financial Officer	$429K	+$164K	+61.6%	May 19, 2025
Steven C. Katz	Chief Medical Officer	$377K			Feb 12, 2024
Magnetar Financial LLC	10%+ Owner	$175K			Jun 12, 2023
Liselotte Hyveled	Director	$39.9K			Jan 2, 2025
Andrew C. Von Eschenbach	Director				Aug 13, 2024
Kerry R. Hicks	Director				Jun 12, 2025
William Valle	Director				Jun 12, 2025
Anil K. Singhal	Director				Aug 13, 2024
Gary B. Gordon	Director				Jun 12, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.